Free Trial
NASDAQ:MDCX

Medicus Pharma (MDCX) Stock Price, News & Analysis

Medicus Pharma logo
$6.16 -1.13 (-15.50%)
As of 05/27/2025 04:00 PM Eastern

About Medicus Pharma Stock (NASDAQ:MDCX)

Key Stats

Today's Range
$6.00
$7.73
50-Day Range
$3.13
$7.78
52-Week Range
$1.80
$8.94
Volume
373,149 shs
Average Volume
86,402 shs
Market Capitalization
$83.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.50
Consensus Rating
Strong Buy

Company Overview

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.

Medicus Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
34th Percentile Overall Score

MDCX MarketRank™: 

Medicus Pharma scored higher than 34% of companies evaluated by MarketBeat, and ranked 729th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medicus Pharma has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Medicus Pharma has only been the subject of 3 research reports in the past 90 days.

  • Read more about Medicus Pharma's stock forecast and price target.
  • Short Interest

    There is no current short interest data available for MDCX.
  • Dividend Yield

    Medicus Pharma does not currently pay a dividend.

  • Dividend Growth

    Medicus Pharma does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for MDCX.
  • News Sentiment

    Medicus Pharma has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Medicus Pharma this week, compared to 2 articles on an average week.
  • Search Interest

    6 people have searched for MDCX on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 5 people have added Medicus Pharma to their MarketBeat watchlist in the last 30 days. This is a decrease of -29% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medicus Pharma insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $579,000.00 in company stock.

  • Read more about Medicus Pharma's insider trading history.
Receive MDCX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicus Pharma and its competitors with MarketBeat's FREE daily newsletter.

MDCX Stock News Headlines

Medicus Pharma begins UAE cancer trial expansion – ICYMI
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Medicus Pharma begins UAE cancer trial expansion – ICYMI
Medicus Pharma Ltd
See More Headlines

MDCX Stock Analysis - Frequently Asked Questions

Medicus Pharma's stock was trading at $2.43 at the beginning of 2025. Since then, MDCX stock has increased by 153.5% and is now trading at $6.16.
View the best growth stocks for 2025 here
.

Medicus Pharma Ltd. (NASDAQ:MDCX) announced its quarterly earnings data on Monday, May, 12th. The company reported ($0.42) EPS for the quarter, missing the consensus estimate of ($0.23) by $0.19.

Medicus Pharma (MDCX) raised $4 million in an initial public offering on Thursday, November 14th 2024. The company issued 1,000,000 shares at a price of $4.13 per share. Maxim Group LLC served as the underwriter for the IPO and Brookline Capital Markets was co-manager.

Medicus Pharma's top institutional investors include Interchange Capital Partners LLC (12.39%), Armistice Capital LLC (9.43%) and Private Advisor Group LLC (0.42%).
View institutional ownership trends
.

Shares of MDCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/12/2025
Today
5/28/2025
Next Earnings (Estimated)
6/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MDCX
Previous Symbol
NASDAQ:MDCX
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.50
High Stock Price Target
$27.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+281.5%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$83.13 million
Optionable
N/A
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:MDCX) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners